No one, and I mean no one, understands drug pricing and the policies around regulating them like Stacie Dusetzina, PhD, from the Department of Health Policy at Vanderbilt University School of Medicine, does. So, I was fortunate to have her as my guest on the podcast to discuss the “desensitization” of society to cancer prescription drug costs, the role of advancing science in research and development and drug approvals for rare diseases, the H.R.3 bill in front of Congress, and solutions proposed by politicians for inflated Medicare Part D spending, among other topics.
Observations and Commentary on Medicine and Current Events
